The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Evidence‐based medical review update: Pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004
Abstract
The objective of this study is to update a previous evidence‐based medicine (EBM) review on Parkinson's disease (PD) treatments, adding January 2001 to January 2004 information. The Movement Disorder Society (MDS) Task Force prepared an EBM review of PD treatments covering data up to January 2001. The authors reviewed Level I (randomized clinical trials) reports of pharmacological and surgical interventions for PD, published as full articles in English (January 2001–January 2004). Inclusion criteria and ranking followed the original program and adhered to EBM methodology. For Efficacy Conclusions, treatments were designated Efficacious, Likely Efficacious, Non‐Efficacious, or Insufficient Data. Four clinical indications were considered for each intervention: prevention of disease progression; treatment of Parkinsonism, as monotherapy and as adjuncts to levodopa where indicated; prevention of motor complications; treatment of motor complications. Twenty‐seven new studies qualified for efficacy review, and others covered new safety issues. Apomorphine, piribedil, unilateral pallidotomy, and subthalamic nucleus stimulation moved upward in efficacy ratings. Rasagiline, was newly rated as Efficacious monotherapy for control of Parkinsonism. New Level I data moved human fetal nigral transplants, as performed to date, from Insufficient Data to Non‐ efficacious for the treatment of Parkinsonism, motor fluctuations, and dyskinesias. Selegiline was reassigned as Non‐efficacious for the prevention of dyskinesias. Other designations did not change. In a field as active in clinical trials as PD, frequent updating of therapy‐based reviews is essential. We consider a 3‐year period a reasonable time frame for published updates and are working to establish a Web‐based mechanism to update the report in an ongoing manner. © 2005 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evidence-Based Medicine: How to Practice and Teach EBM
Sackett, D. L. (2000) · Cited by 5,950
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
Freed, C. R., Greene, P. E., Breeze, R. E., Tsai, W.-Y., DuMouchel, W., Kao, R., Dillon, S., Winfield, H., Culver, S., Trojanowski, J. Q., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441002 · Cited by 2,366
Evidence-Based Medicine: How to Practice and Teach EBM
Satya-Murti, S. (2000) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.284.18.2382 · Cited by 1,643
A double‐blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease
Olanow, C. W., Goetz, C. G., Kordower, J. H., Stoessl, A. J., Sossi, V., Brin, M. F., Shannon, K. M., Nauert, G. M., Perl, D. P., Godbold, J., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10720 · Cited by 1,307
Self-citationTRANSPLANTATION OF EMBRYONIC DOPAMINE NEURONS FOR SEVERE PARKINSON'S DISEASE
Reed, R., Reene, P. A. E. G., Reeze, R. O. E. B., Ei, W., Ouchel, W. I. D. U. M., Ao, R. I. K., Infield, W., Ulver, S. H. C., Rojanowski, J. O. Q. T., Idelberg, D. A. E., et al. (2001) · Cited by 1,001
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study
Whone, A. L., Watts, R. L., Stoessl, A. J., Davis, M., Reske, S., Nahmias, C., Lang, A. E., Rascol, O., Ribeiro, M. J., Remy, P., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10609 · Cited by 829
Self-citationPramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial
Holloway, R. G., Shoulson, I., Kieburtz, K. D., McDermott, M., Tariot, P. N., Kamp, C., Day, D., Shinaman, A., Fahn, S., Lang, A. E., et al. (2000) · JAMA · Cited by 798
Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease: A Randomized Controlled Trial
Parkinson Study Group (2000) · JAMA · doi:10.1001/jama.284.15.1931 · Cited by 767
Parkinson Study Group (2002) · JAMA · doi:10.1001/jama.287.13.1653 · Cited by 711
A Controlled Trial of Rasagiline in Early Parkinson Disease: The TEMPO Study
(2002) · Archives of Neurology · doi:10.1001/archneur.59.12.1937 · Cited by 579
Funkiewiez, A. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2002.009803 · Cited by 572
Hobson, D. E., Lang, A. E., Martin, W. R. W., Razmy, A., Rivest, J., & Fleming, J. (2002) · JAMA · doi:10.1001/jama.287.4.455 · Cited by 553
Meta-analysis of randomised controlled trials
Kelly, C. P. (1997) · The Lancet · doi:10.1016/s0140-6736(05)63834-2 · Cited by 382
Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease
Van Camp, G., Flamez, A., Cosyns, B., Weytjens, C., Muyldermans, L., Van Zandijcke, M., De Sutter, J., Santens, P., Decoodt, P., Moerman, C., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15945-x · Cited by 321
Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease
Paus, S., Brecht, H. M., Köster, J., Seeger, G., Klockgether, T., & Wüllner, U. (2003) · Movement Disorders · doi:10.1002/mds.10417 · Cited by 295
Anticholinergics for symptomatic management of Parkinson´s disease
Katzenschlager, R., Sampaio, C., Costa, J., & Lees, A. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003735 · Cited by 259
Self-citationShoulson, I., Oakes, D., Fahn, S., Lang, A., Langston, J. W., LeWitt, P., Olanow, C. W., Penney, J. B., Tanner, C., Kieburtz, K., et al. (2002) · Annals of Neurology · doi:10.1002/ana.10191 · Cited by 258
Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: A randomized trial
Esselink, R. A. J., de Bie, R. M. A., de Haan, R. J., Lenders, M. W. P. M., Nijssen, P. C. G., Staal, M. J., Smeding, H. M. M., Schuurman, P. R., Bosch, D. A., & Speelman, J. D. (2004) · Neurology · doi:10.1212/01.wnl.0000103235.12621.c3 · Cited by 254
Duration of amantadine benefit on dyskinesia of severe Parkinson's disease.
Thomas, A., Iacono, D., Luciano, A. L., Armellino, K., Iorio, A. D., & ONOFRJ, M. C. (2004) · PubMed Central · Cited by 246
Randomized trial of pallidotomy versus medical therapy for Parkinson's disease
Vitek, J. L., Bakay, R. A. E., Freeman, A., Evatt, M., Green, J., McDonald, W., Haber, M., Barnhart, H., Wahlay, N., Triche, S., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10517 · Cited by 243
Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs
Perry, E. K., Kilford, L., Lees, A. J., Burn, D. J., & Perry, R. H. (2003) · Annals of Neurology · doi:10.1002/ana.10639 · Cited by 231
Østergaard, K., Sunde, N., & Dupont, E. (2002) · Movement Disorders · doi:10.1002/mds.10188 · Cited by 217
Poewe, W. H., Deuschl, G., Gordin, A., Kultalahti, E.-R., Leinonen, M., & the Celomen Study Group (2002) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2002.1o174.x · Cited by 211
Self-citationAn algorithm (decision tree) for the management of Parkinson's disease: Treatment guidelines
Olanow, C. W., & Koller, W. C. (1998) · Neurology · doi:10.1212/wnl.50.3_suppl_3.s1 · Cited by 203
Management of Parkinson's disease: An evidence-based review
Lang, A. E., & Lees, A. (2002) · Movement Disorders · doi:10.1002/mds.5554 · Cited by 184
Brooks, D. J. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.8.1071 · Cited by 182
Razmy, A., Lang, A. E., & Shapiro, C. M. (2004) · Archives of Neurology · doi:10.1001/archneur.61.1.97 · Cited by 178
Pogarell, O. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.6.713 · Cited by 165
Doshi, P. K., Chhaya, N., & Bhatt, M. H. (2002) · Movement Disorders · doi:10.1002/mds.10198 · Cited by 157
Dotto, P. D., Pavese, N., Gambaccini, G., Bernardini, S., Metman, L. V., Chase, T. N., & Bonuccelli, U. (2001) · Movement Disorders · doi:10.1002/mds.1112 · Cited by 153
Stiff person syndrome with eye movement abnormality, myasthenia gravis, and thymoma
Thomas, S. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.036558 · Cited by 149
Ten-year follow-up of three different initial treatments in de-novo PD
Lees, A. J., Katzenschlager, R., Head, J. A., & Ben‐Shlomo, Y. (2001) · Neurology · doi:10.1212/wnl.57.9.1687 · Cited by 143
Goetz, C. G., Leurgans, S. E., & Raman, R. (2002) · Movement Disorders · doi:10.1002/mds.10024 · Cited by 135
Self-citationKoller, W. C., Lees, A. J., Doder, M., Hely, M. A., & the Tolcapone/Pergolide Study Group (2001) · Movement Disorders · doi:10.1002/mds.1175 · Cited by 81
Increased daytime sleepiness in Parkinson's disease: A questionnaire survey
Högl, B., Seppi, K., Brandauer, E., Glatzl, S., Frauscher, B., Niedermüller, U., Wenning, G. K., & Poewe, W. H. (2002) · Movement Disorders · doi:10.1002/mds.10365 · Cited by 79
Self-citationKatayama, Y., Kasai, M., Oshima, H., Fukaya, C., Yamamoto, T., Ogawa, K., & Mizutani, T. (2001) · Journal of neurosurgery · doi:10.3171/jns.2001.95.2.0213 · Cited by 78
Increased Risk of Somnolence with the New Dopamine Agonists in Patients with Parkinson??s Disease
Etminan, M., Samii, A., Takkouche, B., & Rochon, P. A. (2001) · Drug Safety · doi:10.2165/00002018-200124110-00007 · Cited by 67
Brunt, E. R., Brooks, D. J., Korczyn, A. D., Montastruc, J., & Stocchi, F. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200040 · Cited by 66
F�nelon, G., Gim�nez-Rold�n, S., Montastruc, J., Bermejo, F., Durif, F., Bourdeix, I., P�r�, J.-J., Galiano, L., & Schadrack, J. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0799-z · Cited by 64
Ziegler, M., Castro‐Caldas, A., Signore, S. D., & Rascol, O. (2003) · Movement Disorders · doi:10.1002/mds.10359 · Cited by 60
Self-citationRakshi, J. S., Pavese, N., Uema, T., Ito, K., Morrish, P., Bailey, D. L., & Brooks, D. J. (2002) · Journal of Neural Transmission · doi:10.1007/s00702-002-0753-0 · Cited by 59
Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD
Smeding, H. M. M., Esselink, R. A. J., Schmand, B. A., Koning-Haanstra, M., Nijhuis, I. J. M., Wijnalda, E. M., & Speelman, J. D. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0628-z · Cited by 49
Gait Analysis in Advanced Parkinson's Disease – Effect of Levodopa and Tolcapone
Shan, D., Lee, S.-J., Chao, L.-Y., & Yeh, S.-I. (2001) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100052598 · Cited by 46
Neuropsychological and psychiatric sequelae of pallidotomy for PD
Green, J., McDonald, W. M., Vitek, J. L., Haber, M., Barnhart, H. X., Bakay, R. A. E., Evatt, M. L., Freeman, A., Wahlay, N., Triche, S. D., et al. (2002) · Neurology · doi:10.1212/wnl.58.6.858 · Cited by 45
Montastruc, J., Desboeuf, K., Lapeyre‐Mestre, M., Sénard, J., Rascol, O., & Brefel‐Courbon, C. (2001) · Movement Disorders · doi:10.1002/mds.1093 · Cited by 32
Self-citationDjaldetti, R., Inzelberg, R., Giladi, N., Korczyn, A. D., Peretz-Aharon, Y., Rabey, M. J., Herishano, Y., Honigman, S., Badarny, S., & Melamed, E. (2002) · Movement Disorders · doi:10.1002/mds.10075 · Cited by 32
Cognition following bilateral implants of embryonic dopamine neurons in PD
Trott, C. T., Fahn, S., Greene, P., Dillon, S., Winfield, H., Winfield, L. M., Kao, R., Eidelberg, D., Freed, C. R., Breeze, R. E., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000070181.28651.3b · Cited by 27
Cited by
A Randomized Trial of Deep-Brain Stimulation for Parkinson's Disease
Deuschl, G., Schade-Brittinger, C., Krack, P., Volkmann, J., Schäfer, H., Bötzel, K., Daniels, C., Deutschländer, A., Dillmann, U., Eisner, W., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060281 · Cited by 2,944
Self-citationNon-motor symptoms of Parkinson's disease: diagnosis and management
Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807
Seppi, K., Weintraub, D., Coelho, M., Perez‐Lloret, S., Fox, S. H., Katzenschlager, R., Hametner, E., Poewe, W., Rascol, O., Goetz, C. G., et al. (2011) · Movement Disorders · doi:10.1002/mds.23884 · Cited by 1,141
Self-citationFox, S. H., Katzenschlager, R., Lim, S., Barton, B., de Bie, R. M. A., Seppi, K., Coelho, M., Sampaio, C., & on behalf of the Movement Disorder Society Evidence‐Based Medicine Committee (2018) · Movement Disorders · doi:10.1002/mds.27372 · Cited by 1,002
Self-citationSubthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomes
Kleiner-Fisman, G., Herzog, J., Fisman, D. N., Tamma, F., Lyons, K. E., Pahwa, R., Lang, A. E., & Deuschl, G. (2006) · Movement Disorders · doi:10.1002/mds.20962 · Cited by 957
Metadata
- Authors
- Goetz, C. G., Poewe, W., Rascol, O., & Sampaio, C.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2005-04-07
- Volume
- 20
- Issue
- 5
- Pages
- 523-539
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2089797759
- Cited by
- 376
- References
- 47
- FWCI
- 19.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.